NMI Technologietransfer GmbH
Profile
NMI Technologie Transfer GmbH in Reutlingen develops and operates contract research services for pharmaceutical and biotech companies, covering protein profiling, cell assays and electrophysiology, as well as microdevices.
Services
Evidenced: named on the company’s own website. Unclear: checked, nothing conclusive found.
| Service | Status | EvidenceQuote from the company’s website (German) |
|---|---|---|
| Bioanalysis Testing and analytics |
Evidenced |
„Our protein profiling offerings can support Phase I, Phase II and Phase III clinical trials with monitoring pharmacokinetic (PK) and pharmacodynamic (PD) markers.“ Source · 10 Nov 2026 ↗ |
| Analytical method development and validation Testing and analytics |
Evidenced |
„With many years in setting up custom immunoassays, we develop and validate assays on demand.“ Source · 10 Nov 2026 ↗ |
Official credentials
Manufacturing authorisation
The competent authority of the federal state authorises the site to manufacture, test or import medicinal products (Section 13 of the German Medicinal Products Act, AMG). Without this authorisation it may not do so.
DE_BW_01_MIA_2015_0036
Reutlingen
Source: EMA/EudraGMDP, reported by the competent state authority · as of 10 Nov 2026 ↗GMP certificate
The authority has inspected the site and confirmed that it complies with Good Manufacturing Practice (GMP).
DE_BW_01_GMP_2023_0204
Reutlingen
Source: EMA/EudraGMDP, reported by the competent state authority · as of 10 Nov 2026 ↗Sites
Markwiesenstr. 55
72770 Reutlingen